Akeho Naoki, Muta Kumiko, Torigoe Kenta, Kitamura Mineaki, Sawada Takaaki, Nakamura Kimitoshi, Mukae Hiroshi, Nishino Tomoya
Department of Nephrology, Izumikawa Hospital, Minamishimabara, JPN.
Department of Nephrology, Nagasaki University Hospital, Nagasaki, JPN.
Cureus. 2024 Jul 9;16(7):e64127. doi: 10.7759/cureus.64127. eCollection 2024 Jul.
A 15-year-old male has been experiencing fever, limb pain during exercise, and reduced sweating since childhood. During an investigation into his fever, a family history of Fabry disease was discovered, prompting a referral to our department. He was diagnosed with Fabry disease based on decreased alpha-galactosidase A (α-Gal A) activity. Concurrently, his mother was found to have experienced limb pain during fevers since childhood, and she was also diagnosed with Fabry disease based on decreased α-Gal A activity. In the genetic analysis of both individuals, the IVS1+17A>G GLA variant was identified. This variant is considered benign and not classified as a pathogenic variant. Enzyme replacement therapy has been effective in improving clinical symptoms. His sister, who has not been diagnosed with Fabry disease due to normal clinical symptoms and α-GAL A activity, also had the same variant. Among the various GLA variants, many are classified as benign rather than pathogenic. In the present cases, the possibility of other factors that cannot be identified by genetic analysis is suggested, making this case significant and worth reporting.
一名15岁男性自幼出现发热、运动时肢体疼痛及出汗减少症状。在对其发热情况进行调查时,发现有法布里病家族史,遂转诊至我科。根据α - 半乳糖苷酶A(α - Gal A)活性降低,他被诊断为法布里病。同时,发现其母亲自幼发热时也有肢体疼痛症状,基于α - Gal A活性降低,她也被诊断为法布里病。在对两人的基因分析中,鉴定出IVS1 + 17A>G GLA变异。该变异被认为是良性的,未被归类为致病变异。酶替代疗法已有效改善临床症状。他的姐姐因临床症状和α - GAL A活性正常未被诊断为法布里病,但也有相同变异。在各种GLA变异中,许多被归类为良性而非致病性。在本病例中,提示存在基因分析无法识别的其他因素的可能性,使得该病例具有重要意义且值得报告。